FOUNDAO

Serial Number 99358614
681

Registration Progress

Application Filed
Aug 26, 2025
Under Examination
Approved for Publication
Published for Opposition
Nov 25, 2025
Registered

Attorney Assistance

Non-Final Action E-Mailed
Due: Jan 27, 2026 77 days

Trademark Image

FOUNDAO

Basic Information

Serial Number
99358614
Filing Date
August 26, 2025
Published for Opposition
November 25, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
681
Status Date
Nov 4, 2025
Application
Pending
Classes
005

Rights Holder

Eli Lilly and Company

03
Address
Lilly Corporate Center
Indianapolis, IN 46285

Ownership History

Eli Lilly and Company

Original Applicant
03
Indianapolis, IN

Legal Representation

Attorney
Bruce W. Longbottom

USPTO Deadlines

Next Deadline
77 days remaining
Non-Final Action E-Mailed
Due Date
January 27, 2026
Extension Available
Until April 27, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

8 events
Date Code Type Description Documents
Oct 27, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 27, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 27, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 27, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 22, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 26, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Aug 26, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 26, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, peripheral arterial disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Classification

International Classes
005